Clinical trials
Uterine Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Completed | 4 |
| Unknown status | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 3 |
| AstraZeneca | 2 |
| Astellas Pharma Inc | 1 |
| Fore Biotherapeutics | 1 |
| Incyte Corporation | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| Nottingham University Hospitals NHS Trust | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Neoplasms | 15 |
| Endometrial Neoplasms | 9 |
| Ovarian Neoplasms | 7 |
| Neoplasms | 5 |
| Uterine Cervical Neoplasms | 5 |
| Vulvar Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Urinary Bladder Neoplasms | 3 |
| Vaginal Neoplasms | 3 |
Trials
Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.